§ 300aa-23. Trial
(b)
Liability
The first stage of such a civil action shall be held to determine if a vaccine manufacturer is liable under section
300aa–22 of this title.
(c)
General damages
The second stage of such a civil action shall be held to determine the amount of damages (other than punitive damages) a vaccine manufacturer found to be liable under section
300aa–22 of this title shall be required to pay.
(d)
Punitive damages
(1)
If sought by the plaintiff, the third stage of such an action shall be held to determine the amount of punitive damages a vaccine manufacturer found to be liable under section
300aa–22 of this title shall be required to pay.
(2)
If in such an action the manufacturer shows that it complied, in all material respects, with all requirements under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.] and this chapter applicable to the vaccine and related to the vaccine injury or death with respect to which the action was brought, the manufacturer shall not be held liable for punitive damages unless the manufacturer engaged in—
(A)
fraud or intentional and wrongful withholding of information from the Secretary during any phase of a proceeding for approval of the vaccine under section
262 of this title,
(B)
intentional and wrongful withholding of information relating to the safety or efficacy of the vaccine after its approval, or
which activity related to the vaccine-related injury or death for which the civil action was brought.
(e)
Evidence
In any stage of a civil action, the Vaccine Injury Table, any finding of fact or conclusion of law of the United States Court of Federal Claims or a special master in a proceeding on a petition filed under section
300aa–11 of this title and the final judgment of the United States Court of Federal Claims and subsequent appellate review on such a petition shall not be admissible.